(Q47675296)

English

Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

Effects of interferon and ribavirin combination therapy on CD4+ proliferation, lymphocyte activation, and Th1 and Th2 cytokine profiles in chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

0 references

1 reference

based on heuristic

inferred from title

Rui Tato Marinho

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

author name string

R Pinto

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

M L Santos

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

I V Lobos

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

M C Moura

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

206-216

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

Immunopathogenesis of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Cellular immune responses against hepatitis C virus: the evidence base 2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

The Th1/Th2 paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Mechanisms of interleukin-10-mediated immune suppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Modulation by biologic response modifiers of hepatitis C virus antigen-independent cytokine secretion in blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Lack of evidence for the Th2 predominance in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Lymphocyte subsets in renal allograft recipients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Profiles of cytokines produced by CD4-positive T lymphocytes stimulated by anti-CD3 antibody in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2004.00496.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2004.00496.X

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15117322

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47675296&oldid=1365493956"